A customizable, drug-free long-term pain treatment solution for better quality of life.
Remedee Labs has developed the first millimeter-wave-emitting bracelet that stimulates the production of endorphins, the body's natural analgesics. It also offers an online service platform to bring patients multidisciplinary pain management backed by personalized support.
Remedee Labs has developed a total treatment package: an endorphin-stimulating bracelet based on millimeter-wave technology, a personalized support program, and digital services.
Millimeter-wave treatment was used successfully on millions of pain patients in the1970s. Over time, however, the treatment, which could only be administered in hospitals due to the large equipment used, has been replaced by pain medication. Remedee Labs is putting millimeter-wave technology at everyone’s fingertips with a simple bracelet equipped with a microelectronic chip that stimulates natural endorphin production.
Two clinical studies have confirmed the effectiveness of this solution with patients suffering from fibromyalgia and osteoarthritis, at Grenoble University Medical Center. The goal is to obtain medical device approval for the bracelet in 2024.
The startup is offering an initial non-medical bracelet, Remedee Well, to improve users’ day-to-day well being. The package includes the bracelet plus access to the online platform.
Remedee Labs has a portfolio of nine patents, including X CEA patents. It is collaborating with the CEA on imaging-based brain evaluation of the physiological effects of its technology.
Key figure: 70%
12 million people in France suffer from chronic pain, and 70% of them do not receive appropriate treatment
Possible uses (clinical trials in progress)
- Fibromyalgia
- Osteoarthritis
- Chronic migraines
Technologies
- 2 cm2 miniaturized electronic module integrated into a bracelet
- 60 GHz millimeter-wave-emitting silicon chip
Year founded: 2016
CEA institutes: CEA-Leti
www.remedee.com